A novel class of radiopharmaceuticals has proven effective in non-invasively identifying nearly 30 types of malignant tumors. Using 68Ga-FAPI PET/CT, researchers were able to image the tumors with very high uptake and image contrast, paving the way for new applications in tumor characterization, staging and therapy.
from Latest Science News -- ScienceDaily http://bit.ly/2QXYy14
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment